Literature DB >> 29886678

[Trend analysis on incidence and age at diagnosis for lung cancer in cancer registration areas of China, 2000-2014].

S W Zhang1, R S Zheng, Z X Yang, H M Zeng, K X Sun, X Y Gu, H Li, W Q Chen, J He.   

Abstract

Objective: To analyze the incidence trend and mean age at diagnosis for lung cancer in cancer registration areas of China from 2000 to 2014.
Methods: The data of lung cancer incidence used in this study were from 22 registries submitted to National Central Cancer Registry with continuous data during 2000 and 2014, covering about 621 593 469 person-years. All cancer cases were coded as C33-C34 according to the International Classification of Diseases-10(th) Revision (ICD-10) were extracted for this analysis with about 343 663 patients. The incidence of different sex and regional population, the standardized incidence rate by Chinese population, the average annual change percentage (AAPC), the mean age and adjusted mean age of cancer incidence were calculated. The incidence of each year was described by regional and age groups, and the linear regression model was employed to analyze the relationship between mean age at onset and year.
Results: The crude incidence rate and age-standardized incidence rate (ASR) of lung cancer for men in cancer registry areas in 2000 were 56.98 per 100 000 and 48.43 per 100 000, respectively. The rates were 89.51 per 100 000 and 46.85 per 100 000 in 2014, respectively. For women in the same areas, the rates were 27.77 per 100 000 and 20.17 per 100 000 in 2000; while 51.31 per 100 000 and 25.44 per 100 000 in 2014, respectively. The crude incidence rate increased along with the age. In 2000-2014, the trend of crude rate and ASR of lung cancer were significantly increased (CR: AAPC=3.8%, 95%CI: 3.5%-4.1%; ASR: AAPC=0.4%, 95%CI: 0.2%-0.7%). The rise of crude rate in females was higher than that in males (Male: AAPC=3.5%, 95%CI: 3.2%-3.7%; Female: AAPC=4.5%, 95%CI: 4.1%-5.0%). However, the rise of the ASR declined for both male and female (Male: AAPC=-0.2%, 95%CI:-0.4%-0.0%; Female: AAPC=1.4%, 95%CI: 1.0%-1.9%). The average age at diagnosis of lung cancer in rural areas was 64.35 years old in 2000, and increased to 65.97 years old in 2014 (β=0.11, P<0.001), while adjusted mean age at onset remained stable in all areas and urban areas (P>0.05). And the average age at onset increased significantly over time in male (β=-0.02, P=0.014), which was not seen in female (β=-0.01, P=0.522).
Conclusion: The crude incidence rate of lung cancer in cancer registry areas in China increased slowly during 2000-2014; and the standardized average age of male at diagnosis decreased slightly, while the age in rural areas increased during 2000-2014. Lung cancer will still be the focus of cancer prevention and control in the near future.

Entities:  

Keywords:  Age of onset; Average annual percent change; Cross-sectional studies; Lung neoplasms

Mesh:

Year:  2018        PMID: 29886678     DOI: 10.3760/cma.j.issn.0253-9624.2018.06.005

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  7 in total

1.  Tobacco smoking and trends in histological subtypes of female lung cancer at the Cancer Hospital of the Chinese Academy of Medical Sciences over 13 years.

Authors:  Qiang Zeng; Emily Vogtmann; Man-Man Jia; Mark Parascandola; Ji-Bin Li; Yan-Ling Wu; Qin-Fu Feng; Xiao-Nong Zou
Journal:  Thorac Cancer       Date:  2019-07-10       Impact factor: 3.500

2.  Prehabilitation in video-assisted thoracoscopic surgery lobectomy for lung cancer: current situation and future perspectives.

Authors:  Zi-Jia Liu; Yue-Lun Zhang; Yu-Guang Huang
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

3.  Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China.

Authors:  Dawei Zhu; Xuefeng Shi; Stephen Nicholas; Yong Ma; Ping He
Journal:  Cancer Med       Date:  2021-03-21       Impact factor: 4.452

4.  Menstrual factors, reproductive history, and risk of lung cancer: a multi-center population-based cohort study in Chinese females.

Authors:  Zhuoyu Yang; Fei Wang; Fengwei Tan; Wei Cao; Yongjie Xu; Chao Qin; Yiwen Yu; Liang Zhao; Yan Wen; Zheng Wu; Yadi Zheng; Yunyong Liu; Lianzheng Yu; Donghua Wei; Dong Dong; Ji Cao; Shaokai Zhang; Shipeng Yan; Ning Wang; Xianzhen Liao; Lingbin Du; Jiang Li; Ni Li; Wanqing Chen; Jie He
Journal:  Transl Lung Cancer Res       Date:  2021-10

5.  [Analysis on the Incidence and Economic Burden of Patients with Lung Cancer].

Authors:  Guo Tian; Li Bian; Xiaoli Xu; Shumei Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-03-20

Review 6.  Epidemiology of lung cancer in China.

Authors:  Maomao Cao; Wanqing Chen
Journal:  Thorac Cancer       Date:  2018-11-28       Impact factor: 3.500

7.  Analysis of Segmental Lymph Node Metastasis and Clinical Features in cT1N0M0 Lung Adenocarcinoma.

Authors:  Guanghao Sun; Yanbin Sun; Zifang Zou; Shun Xu
Journal:  Biomed Res Int       Date:  2020-02-18       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.